U.K.-based Molecular Profiles says its new £9 million $13.6 million), 30,000-square-foot pharmaceutical production plant in Nottingham is now open for business. The facility will manufacture products for clinical trials and can handle non-sterile dosage forms such as solids, liquids, semi-solids and inhaled products, Contract Pharma reports. The facility has 6 GMP suites and new labs, as well as a clinical packing area to support Phase I and II clinical trials. Report